OptimizeRx Corporation

OptimizeRx Corporation

OPRX·NASDAQ

$5.53

+11%
HealthcareMedical - Healthcare Information Services

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

At a Glance

Live Snapshot
Market Cap$103.77M
EPS0.2800
P/E Ratio19.75
Earnings Date08/06/2026
5.56%
Return on Invested Capital
-163%
3Y-157.0%
5Y-231.0%
10Y-127.0%
4.00%
Return on Equity
-123%
3Y-144.0%
5Y-191.0%
10Y-120.0%
2.90%
Return on Assets
-125%
3Y-134.0%
5Y-179.0%
10Y-122.0%
OptimizeRx Corporation

OptimizeRx Corporation Management Team

OPRX · NASDAQ
MT

Ms. Theresa Greco

Chief Commercial Officer

Born 1973(Age 53)
female
ME

Mr. Edward Stelmakh C.M.A., M.B.A.

Chief Financial Officer & Chief Operating Officer

Compensation

$578,479

Born 1966(Age 60)
male
MM

Ms. Marion K Odence-Ford

Chief Legal Officer & Chief Human Resources Officer

Compensation

$428,117

Born 1965(Age 61)
female
DD

Dr. Doug Besch

Chief Product Officer & Chief Technology Officer

Born 1982(Age 44)
MH

Ms. Heather Favazza

Controller

female
MS

Ms. Sheryl Kearney

Human Resources Manager

female
MM

Ms. Maira Alejandra

Media Relations Manager

female
MS

Mr. Stephen L. Silvestro

President & Chief Executive Officer

Compensation

$544,960

Born 1978(Age 48)
male
MA

Mr. Andrew Jacob D'Silva

Senior Vice President of Corporate Finance

male
oprx

OptimizeRx Corporation Insider Positioning

OPRX · NASDAQ

During the last 12 months, insiders have purchased $3.22M and sold $281K worth of OPRX shares, resulting in $2.93M of net buying activity.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

1.4K

18.75K

Net Activity

-19K

-$19K

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

199.2K

3.22M

Sold

24.8K

262.42K

Net Activity

+3.0M

+$2.95M

Top Buyers

1
SSL

Silvestro Stephen L

Officer: Chief Executive Officer

35.2K shares1 transactions

$567K

2
OM

Odence-Ford Marion

Officer: Chief Legal & Admin Officer

35.2K shares1 transactions

$567K

3
SE

Stelmakh Edward

Officer: Cfo/Coo

35.2K shares1 transactions

$567K

4
BD

Besch Doug

Officer: Chief Prod & Tech Officer

35.2K shares1 transactions

$567K

5
GT

Greco Theresa

Officer: Chief Commercial Officer

35.2K shares1 transactions

$567K

Top Sellers

1
SPD

Spangler Patrick D

Director

11.1K shares1 transactions

$194K

2
DAJ

D'Silva Andrew J.

Officer: Chief Business Officer

13.7K shares1 transactions

$68K

3
SE

Stelmakh Edward

Officer: Chief Finance & Strat Officer

1.4K shares1 transactions

$19K

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $2.93M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

11.44:1

Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.

Insider Participation

Moderate Buying

5 insider buyers vs. 3 sellers. More insiders buying than selling indicates positive sentiment.

Insider Activity Insight

Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.

SEC Filings

OPRX - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

April 30, 2026
June 09, 2026
2026
DEF 14A

DEF 14A 2025

N/A

April 30, 2025
June 11, 2025
2025
DEF 14A

DEF 14A 2024

N/A

April 29, 2024
June 05, 2024
2024
DEF 14A

DEF 14A 2023

N/A

April 25, 2023
June 07, 2023
2023
DEF 14A

DEF 14A 2022

N/A

April 25, 2022
June 09, 2022
2022
DEF 14A

DEF 14A 2021

N/A

July 08, 2021
August 19, 2021
2021
DEF 14A

DEF 14A 2020

N/A

October 01, 2020
November 19, 2020
2020
DEF 14A

DEF 14A 2019

N/A

September 24, 2019
November 04, 2019
2019
Showing 1 to 8 of 8 filings